Login / Signup

Efficacy and safety of a novel vaginal medical device in recurrent bacterial vaginosis: a multicenter clinical trial.

Filippo MurinaCiprian CrișanMarius BirișDaniela SîrbuDionisio F BarattiniLuca I ArdolinoElena Casolati
Published in: Minerva ginecologica (2021)
Our research showed that 3 monthly cycles of Polybactum<sup>®</sup> ovules administered after one course of metronidazole vaginal therapy can reduce the rate of Bacterial vaginosis recurrence and improve the vaginal milieu, favoring the growth of vaginal lactobacillus species.
Keyphrases
  • clinical trial
  • healthcare
  • cross sectional
  • bone marrow
  • open label
  • lactic acid